Navigation auf


Center for Molecular Cardiology

Post-ischaemic administration of a mouse Canakinumab-analogue antibody improves experimental stroke outcome. Find out more about this exciting study from Luca Liberale, Giovanni Camici, and colleagues.

A new study showing the beneficial effects of the murine Canakinumab-surrogate antibody in experimental stroke was published in the European Heart Journal.